Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer
Clinical trial NCT06977542 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06977542
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2029-01-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.